Carotid artery disease: stenting versus endarterectomy

Related Experiment Video

Updated: Jul 2, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Andreas Kastrup1, Sonja Schnaudigel, Katrin Wasser

  • 1Department of Neurology, University of Göttingen, Robert-Koch-Str. 40, 37075 Göttingen, Germany. andreas.kastrup@medizin.uni-goettingen.de

Current Atherosclerosis Reports
|August 19, 2008
PubMed

Insights

Carotid endarterectomy (CEA) and carotid angioplasty with stenting (CAS) treat artery blockages. This review compares their trial data, risks, and roles in preventing stroke.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Interventional Cardiology

Background:

  • Atherosclerotic carotid artery stenosis is a significant risk factor for stroke and mortality.
  • Carotid endarterectomy (CEA) is the established treatment for severe symptomatic and selected asymptomatic stenosis.
  • Carotid angioplasty and stenting (CAS) is emerging as an alternative treatment.

Purpose of the Study:

  • To summarize current clinical trial data comparing CEA and CAS.
  • To review potential risk factors associated with both CEA and CAS procedures.
  • To discuss the complementary roles of CEA and CAS in patient management.

Main Methods:

  • Review of existing clinical trial data for CEA and CAS.
  • Analysis of risk factors identified in studies of CEA and CAS.
  • Discussion of treatment strategies based on comparative data.

Main Results:

  • Trial data comparing CEA and CAS are summarized.
  • Key risk factors for CEA and CAS are identified and reviewed.
  • The complementary nature of these interventions is highlighted.

Conclusions:

  • Both CEA and CAS are viable options for managing carotid artery stenosis.
  • Understanding individual patient risk factors is crucial for selecting the optimal treatment.
  • These techniques can play complementary roles in stroke prevention strategies.

More Related Videos

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers12:30

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers

Published on: August 12, 2014

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...